Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software
Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Multiple-Model Bayesian Adaptive Control
Status: Enrolling
Updated:  2/16/2018
Los Angeles County/University of Southern California Medical Center
mi
from
Los Angeles, CA
Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software
Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Multiple-Model Bayesian Adaptive Control
Status: Enrolling
Updated: 2/16/2018
Los Angeles County/University of Southern California Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated:  2/17/2018
VA Greater Los Angeles
mi
from
Los Angeles, CA
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated: 2/17/2018
VA Greater Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated:  2/17/2018
VA Boston
mi
from
Boston, MA
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated: 2/17/2018
VA Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated:  2/17/2018
Boston Med Ctr
mi
from
Boston, MA
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated: 2/17/2018
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor
A Phase II Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor and Other Non-Carcinomas
Status: Enrolling
Updated:  2/19/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor
A Phase II Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor and Other Non-Carcinomas
Status: Enrolling
Updated: 2/19/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
San Diego, CA
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Miami, FL
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Orlando, FL
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Meridian, ID
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Rochester, NY
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Cleveland, OH
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Nashville, TN
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Birmingham, AL
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Fayetteville, AR
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Jonesboro, AR
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
DeLand, FL
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Bardstown, KY
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Bardstown, KY
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Nicholasville, KY
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Nicholasville, KY
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Lincoln, NE
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Erie, PA
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Erie, PA
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated:  2/19/2018
Massachusetts General Hospital
mi
from
Boston, MA
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated: 2/19/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated:  2/19/2018
Stanford Medicine Outpatient Center
mi
from
Redwood City, CA
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated: 2/19/2018
Stanford Medicine Outpatient Center
mi
from
Redwood City, CA
Click here to add this to my saved trials
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated:  2/19/2018
International Research Partners, LLC.
mi
from
Doral, FL
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated: 2/19/2018
International Research Partners, LLC.
mi
from
Doral, FL
Click here to add this to my saved trials
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated:  2/19/2018
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated: 2/19/2018
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated:  2/19/2018
Advantage Clinical Trials
mi
from
Bronx, NY
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Status: Enrolling
Updated: 2/19/2018
Advantage Clinical Trials
mi
from
Bronx, NY
Click here to add this to my saved trials
Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Status: Enrolling
Updated:  2/20/2018
AHF Hollywood Wellness Center
mi
from
Los Angeles, CA
Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Status: Enrolling
Updated: 2/20/2018
AHF Hollywood Wellness Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Status: Enrolling
Updated:  2/20/2018
AHF Wellness Center Oakland
mi
from
Oakland, CA
Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Advancing HIV Prevention and Linkage to Care Among MSM With Gamification
Status: Enrolling
Updated: 2/20/2018
AHF Wellness Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection
Status: Enrolling
Updated:  2/22/2018
Clinical Research Facility
mi
from
San Diego, CA
Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection
Status: Enrolling
Updated: 2/22/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection
Status: Enrolling
Updated:  2/22/2018
Clinical Research Facility
mi
from
Springfield, MA
Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection
Status: Enrolling
Updated: 2/22/2018
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection
Status: Enrolling
Updated:  2/22/2018
Hospital de Agudos "Dr. Carlos Bocalandro"
mi
from
Tres De Febrero,
Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection
Status: Enrolling
Updated: 2/22/2018
Hospital de Agudos "Dr. Carlos Bocalandro"
mi
from
Tres De Febrero,
Click here to add this to my saved trials
Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)
A Phase 1, Multi-center, Single-masked, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Ophthalmologic Safety and Pharmacodynamics of 300mg Single Doses of Tafenoquine (SB 252263) in Adult Healthy Volunteers
Status: Enrolling
Updated:  2/27/2018
GSK Investigational Site
mi
from
Glendale, CA
Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)
A Phase 1, Multi-center, Single-masked, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Ophthalmologic Safety and Pharmacodynamics of 300mg Single Doses of Tafenoquine (SB 252263) in Adult Healthy Volunteers
Status: Enrolling
Updated: 2/27/2018
GSK Investigational Site
mi
from
Glendale, CA
Click here to add this to my saved trials
Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)
A Phase 1, Multi-center, Single-masked, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Ophthalmologic Safety and Pharmacodynamics of 300mg Single Doses of Tafenoquine (SB 252263) in Adult Healthy Volunteers
Status: Enrolling
Updated:  2/27/2018
GSK Investigational Site
mi
from
Overland Park, KA
Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)
A Phase 1, Multi-center, Single-masked, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Ophthalmologic Safety and Pharmacodynamics of 300mg Single Doses of Tafenoquine (SB 252263) in Adult Healthy Volunteers
Status: Enrolling
Updated: 2/27/2018
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)
A Phase 1, Multi-center, Single-masked, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Ophthalmologic Safety and Pharmacodynamics of 300mg Single Doses of Tafenoquine (SB 252263) in Adult Healthy Volunteers
Status: Enrolling
Updated:  2/27/2018
GSK Investigational Site
mi
from
Baltimore, MD
Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)
A Phase 1, Multi-center, Single-masked, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Ophthalmologic Safety and Pharmacodynamics of 300mg Single Doses of Tafenoquine (SB 252263) in Adult Healthy Volunteers
Status: Enrolling
Updated: 2/27/2018
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS
To Assess the Performance of SeptiCyte® Lab to Diagnose Patients Identified as Suspected of Sepsis in General Medical and Surgical Wards With Infection-positive From Infection-negative SIRS
Status: Enrolling
Updated:  2/27/2018
Rhode Island Hospital
mi
from
Providence, RI
The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS
To Assess the Performance of SeptiCyte® Lab to Diagnose Patients Identified as Suspected of Sepsis in General Medical and Surgical Wards With Infection-positive From Infection-negative SIRS
Status: Enrolling
Updated: 2/27/2018
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated:  2/27/2018
Novartis Investigative Site
mi
from
Miami, FL
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/27/2018
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated:  2/27/2018
Novartis Investigative Site
mi
from
Pompano Beach, FL
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/27/2018
Novartis Investigative Site
mi
from
Pompano Beach, FL
Click here to add this to my saved trials
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated:  2/27/2018
Novartis Investigative Site
mi
from
Tallahassee, FL
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/27/2018
Novartis Investigative Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated:  2/27/2018
Novartis Investigator Site
mi
from
Chicago, IL
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/27/2018
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated:  2/27/2018
Novartis Investigative Site
mi
from
Grand Rapids, MI
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/27/2018
Novartis Investigative Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated:  2/27/2018
Novartis Investigative Site
mi
from
Akron, OH
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/27/2018
Novartis Investigative Site
mi
from
Akron, OH
Click here to add this to my saved trials
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated:  2/27/2018
Novartis Investigative Site
mi
from
Greenville, SC
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/27/2018
Novartis Investigative Site
mi
from
Greenville, SC
Click here to add this to my saved trials
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated:  2/27/2018
Novartis Investigative Site
mi
from
Seattle, WA
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/27/2018
Novartis Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated:  2/27/2018
Novartis Investigative Site
mi
from
Ottawa,
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
A Dose Blinded Extension Study to the CBAF312A2201 Study to Evaluate Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling
Updated: 2/27/2018
Novartis Investigative Site
mi
from
Ottawa,
Click here to add this to my saved trials
Kent State University / Price Chopper Employee Wellness Study
Kent State University / Price Chopper Wellness Promotion Study
Status: Enrolling
Updated:  2/27/2018
The Golub Corporation (Price Chopper / Market 32)
mi
from
Schenectady, NY
Kent State University / Price Chopper Employee Wellness Study
Kent State University / Price Chopper Wellness Promotion Study
Status: Enrolling
Updated: 2/27/2018
The Golub Corporation (Price Chopper / Market 32)
mi
from
Schenectady, NY
Click here to add this to my saved trials
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Chicago, IL
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Somers Point, NJ
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Somers Point, NJ
Click here to add this to my saved trials